ArticleKidney diseases (Basel, Switzerland)
The Impact of Change in Body Roundness Index on the Clinical Outcome of New Peritoneal Dialysis Patients.
Article in Kidney diseases (Basel, Switzerland). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Weight gain and central obesity are common in peritoneal dialysis (PD) patients. In the general population, body roundness index (BRI) has been found to be a convenient anthropometric measurement for the assessment of central obesity and visceral adiposity. However, the role of BRI in PD patients has not been explored. Methods: We recruited 145 new PD patients. BRI, body composition by bioimpedance spectroscopy, and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) were measured at baseline and then after 1 year of PD. Patients were stratified into four groups based on their changes in BRI after 1 year of PD, using the traditional BRI cutoff of 5. Outcome measures include patient survival and hospitalization rate. Results: The change in BRI after 1 year of PD had a modest but significant correlation with the change in HOMA-IR ( Conclusion: An increase in BRI after 1 year of PD was associated with worsening of insulin resistance, worse patient survival, and more hospitalization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.